SynthesisFrontiers in immunology2026

A dual-level Bayesian network meta-analysis of first-line immunotherapy in advanced hepatocellular carcinoma: strategy-level and regimen-level evidence.

Qiangqiang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.